For comprehensive information about Parkinson’s diagnosis please visit Parkinson’s Europe website.
Could caffeine in the blood help diagnose Parkinson’s?
Author: Parkinson's Life editorsPublished: 31 January 2018
Prep: Cook: Serves:
Blood caffeine levels could be promising diagnostic biomarkers for early-stage Parkinson’s, Japanese researchers reported in the journal ‘Neurology’ earlier this month.
The study found that people with Parkinson’s had lower levels of caffeine and caffeine metabolites in their blood than people without the disease, at the same consumption rate.
Caffeine concentrations also were decreased in Parkinson’s patients with motor fluctuations than in those without Parkinson’s. However, patients in more severe disease stages did not have lower caffeine levels.
The study’s authors, Dr David Munoz, University of Toronto, and Dr Shinsuke Fujioka, Fukuoka University, suggested that the “decrease in caffeine metabolites occurs from the earliest stages of Parkinson’s.”
They added: “If a future study were to demonstrate similar decreases in caffeine in untreated patients with Parkinson’s […] the implications of the current study would take enormous importance.”
Share this story
PD in Practice
Download Parkinson’s app endorsed by José Mourinho
i-PROGNOSIS helps Parkinson's outcomes via patient data loggingREAD MORE
Awareness-raising Parkinson’s initiatives awarded €3,000 grants
Find out what the awardees hope they achieveREAD MORE
Safety first: new guide offers advice on using herbal drugs to treat Parkinson’s
All the things you should consider before trying a plant-based drugREAD MORE